Table 2.
COVID-19/non-COVID-19 classification results. Class.: classification; Sens.: sensitivity; Spec.: specificity; Prec.: precision; Acc.: accuracy; AUC: area under the curve; Ref.: reference.
Class. | Subjects | Dataset | Method | Sens. (%) or recall | Spec. (%) | Prec. (%) | Acc. (%) | AUC (%) | F1-score | Ref. |
---|---|---|---|---|---|---|---|---|---|---|
COVID-19/ non-COVID-19 |
496 COVID-19 1385 others |
Private + [28, 31] | CNN | 94.06 | 95.47 | N/A | 94.98 | 97.91 | NA | Jin et al. [30] Preprint |
COVID-19/ non-COVID-19 |
N/A | [46] | CNN | ~90 | ~90 | N/A | ~90 | Not clear | ~90 | Singh et al. [32] Peer-reviewed |
COVID-19/ non-COVID-19 |
449 COVID-19 100 normal 98 lung cancer 397 other |
Private + [47, 48] |
DL multitask | 94 | 79 | N/A | 86 | 93 | N/A | Amyar et al. [33] Preprint |
COVID-19/ non-COVID-19 |
349 COVID-19 397 non-COVID-19 |
Private + [47, 49] | ResNet18 | 100.0 | 98.6 | N/A | 99.4 | 99.65 | 99.5 | Ahuja et al. [34] Peer-reviewed |
COVID-19/ non-COVID-19 |
564 COVID-19 660 non-COVID-19 |
[50] | VGG16 based lesion-attention DNN |
88.8 | N/A | 87.9 | 88.6 | 94.0 | 87.9 | Liu et al. [35] Conference proceeding |
COVID-19/ non-COVID-19 |
53 COVID-19 97 other |
Not clear | SVM | 97.56 | 99.68 | 99.62 | 98.71 | N/A | 98.58 | Barstugan et al. [36] Preprint |
COVID-19/ non-COVID-19 |
313 COVID-19 229 without COVID-19 |
Private | UNet | 90.7 | 91.1 | N/A | 90.1 | 95.9 | N/A | Wang et al. [37] Peer-reviewed |
COVID-19/ non-COVID-19 |
51 COVID-19 55 control |
Private | UNet++ | 94.34 | 99.16 | N/A | 98.85 | N/A | N/A | Chen et al. [38] Preprint |
COVID-19/ non-COVID-19 |
723 COVID-19 413 others |
Private | UNet++ + ResNet-50 |
97.4 | 92.2 | N/A | N/A | 99.1 | N/A | Jin et al. [39] Preprint |
COVID-19/ non-COVID-19 |
413 COVID-19 439 non-COVID-19 |
[32, 51] | ResNet-50 + 2D CNN |
91.46 | 94.78 | 95.19 | 93.02 | N/A | N/A | Pathak et al. [42] Peer-reviewed |
COVID-19/ non-COVID-19 |
460 COVID-19 397 non-COVID-19 |
[26, 47] | CNN SqueezeNet |
85.00 | 81.00 | 81.73 | 83.00 | N/A | 83.33 | Polsinelli et al. [43] Preprint |
COVID-19/ non-COVID |
230 COVID-19 130 normal |
Private | AD3D-MIL | 97.9 | NA | 97.9 | 97.9 | 99.0 | 97.9 | Han et al. [44] Peer-reviewed |
COVID-19/ non-COVID |
1029 COVID-19 1695 non-COVID-19 |
Private | AH-Net DenseNet121 |
84.0 | 93.0 | NA | 90.8 | 94.9 | NA | Harmon et al. [45] Peer-reviewed |